Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images

scientific article published on 4 January 2012

Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/JCBFM.2011.177
P932PMC publication ID3318150
P698PubMed publication ID22214903
P5875ResearchGate publication ID51979877

P50authorDavid NuttQ3277223
Ben Fletcher-WatsonQ61415191
Lula RossoQ114411116
Nicola J. KalkQ37828686
David J. BrooksQ38329590
Anne Lingford-HughesQ41330622
Federico TurkheimerQ41330642
P2093author name stringSue J Wilson
Nicoletta Clementi
James F M Myers
P2860cites workBenzodiazepine receptor equilibrium constants for flumazenil and midazolam determined in humans with the single photon emission computer tomography tracer [123I]iomazenil.Q51650434
Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State PrincipleQ59845561
Central benzodiazepine receptor occupancy by zolpidem in the human brain as assessed by positron emission tomographyQ59858902
Physical characteristics of the ECAT EXACT3D positron tomographQ73014085
Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human [...]Q24316082
Estimation of the number of "true" null hypotheses in multivariate analysis of neuroimaging dataQ30648196
Changes of benzodiazepine receptors during chronic benzodiazepine administration in humansQ33857924
A spectral analysis approach for determination of regional rates of cerebral protein synthesis with the L-[1-(11)C]leucine PET methodQ34009095
A new benzodiazepine pharmacology.Q34106026
Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implicationsQ34367180
The pharmacology and mechanisms of action of new generation, non-benzodiazepine hypnotic agentsQ35854608
GABAA-receptor heterogeneity in the adult rat brain: differential regional and cellular distribution of seven major subunitsQ36790682
Exact and approximate rebinning algorithms for 3-D PET data.Q36853656
Structural requirements for eszopiclone and zolpidem binding to the gamma-aminobutyric acid type-A (GABAA) receptor are differentQ39923376
Structure and pharmacology of gamma-aminobutyric acidA receptor subtypes.Q40417870
Detection of benzodiazepine receptor occupancy in the human brain by positron emission tomographyQ41979083
Measuring drug occupancy in the absence of a reference region: the Lassen plot re-visitedQ42414770
Neocortical abnormalities of [11C]-flumazenil PET in mesial temporal lobe epilepsyQ43569633
Imaging the GABA-benzodiazepine receptor subtype containing the alpha5-subunit in vivo with [11C]Ro15 4513 positron emission tomographyQ44079767
Visualization of alpha5 subunit of GABAA/benzodiazepine receptor by 11C Ro15-4513 using positron emission tomographyQ44257887
Quantitative analyses of [¹¹C]Ro15-4513 binding to subunits of GABAA/benzodiazepine receptor in the living human brainQ45834704
GABA-benzodiazepine receptor function in alcohol dependence: a combined 11C-flumazenil PET and pharmacodynamic studyQ46466765
Role of GABAA alpha5-containing receptors in ethanol reward: the effects of targeted gene deletion, and a selective inverse agonistQ46777275
Comparison of plasma input and reference tissue models for analysing [(11)C]flumazenil studiesQ46956296
Blockade of alcohol's amnestic activity in humans by an alpha5 subtype benzodiazepine receptor inverse agonistQ46987358
Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET studyQ47675005
The use of spectral analysis to determine regional cerebral glucose utilization with positron emission tomography and [18F]fluorodeoxyglucose: theory, implementation, and optimization proceduresQ48127599
Saturation analysis in PET--analysis of errors due to imperfect reference regionsQ48164782
Preclinical and clinical pharmacology of TPA023B, a GABAA receptor α2/α3 subtype-selective partial agonist.Q48306835
Spectral analysis of dynamic PET studiesQ48366094
Statistical neuroanatomy of the human inferior frontal gyrus and probabilistic atlas in a standard stereotaxic spaceQ48557699
Correlation between reduced in vivo benzodiazepine receptor binding and severity of psychotic symptoms in schizophreniaQ48823105
A subclass of GABAA/benzodiazepine receptor exclusively localized in the limbic systemQ48827946
Simplified reference tissue model for PET receptor studies.Q48832665
A [11C]Ro15 4513 PET study suggests that alcohol dependence in man is associated with reduced α5 benzodiazepine receptors in limbic regions.Q51036179
Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo.Q51580734
P433issue4
P304page(s)731-744
P577publication date2012-01-04
P1433published inJournal of Cerebral Blood Flow & MetabolismQ14663525
P1476titleCharacterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images
P478volume32